Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
8.78
-0.53 (-5.69%)
At close: Jun 1, 2026, 4:00 PM EDT
8.64
-0.14 (-1.58%)
After-hours: Jun 1, 2026, 5:31 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $92.2 million as of June 1, 2026. Its market cap has increased by 56.84% in one year.
Market Cap
92.20M
Enterprise Value
-29.71M
1-Year Change
56.84%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $92.20M, a decrease of -69.44%. That is a compound annual growth rate of -18.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 97.76M | 14.89% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 105.44M |
| PepGen | 103.75M |
| Rein Therapeutics | 103.27M |
| Biomea Fusion | 99.77M |
| Verrica Pharmaceuticals | 98.95M |
| ProMIS Neurosciences | 96.94M |
| OS Therapies | 95.31M |
| Rani Therapeutics Holdings | 94.90M |